证券代码：688602 证券简称：康鹏科技 公告编号：2025-024 （一）利润分配预案的具体内容 经众华会计师事务所（特殊普通合伙）审计，公司 2024 年实现归属于上市公 司股东的净利润为-49,531,648.34 元，截至 2024 年 12 月 31 日，公司母公司未分 配利润为 400,309,973.54 元。根据 上市公司监管指引第 3 号——上市公司现金 分红》等法律法规、规范性文件及 上海康鹏科技股份有限公司章程》（以下简 称" 公司章程》"）的相关规定，结合公司现阶段经营业绩情况、未来资金投入 需求和公司可持续发展需要，同时兼顾全体股东的长远利益等因素，经董事会决 议，公司 2024 年度利润分配预案为：不进行利润分配，不进行资本公积金转增 股本，不送红股。 本次利润分配方案尚需提交股东大会审议。 （二）本预案未触及其他风险警示情形的说明 上海康鹏科技股份有限公司 关于 2024 年度利润分配方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 利润分配方案内容 （一）董 ...

中信建投证券股份有限公司 关于上海康鹏科技股份有限公司 2024年度募集资金存放与实际使用情况的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐机构"） 作为上海康鹏科技股份有限公司（以下简称"康鹏科技"或"公司"）首次公开 发行股票并上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公 司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关规定，对上海康鹏科技股份有限公司 2024 年度募集资 金存放与使用情况进行了核查，发表如下保荐意见： 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 根据中国证监会于 2023 年 5 月 9 日出具的《关于同意上海康鹏科技股份有 限公司首次公开发行股票注册的批复》（证监许可 [2023] 1007 号）（以下简称"首 次公开发行"），公司获准向社会公开发行人民币普通股 103,875,000 股，每股面 值为人民币 1.00 元，每股发行价格为人民币 8.66 元，募集资金总额为人民币 899,557,500.0 ...

上海康鹏科技股份有限公司 2024 年度 合并财务报表及审计报告 | 内容 | 页码 | | --- | --- | | 审计报告 | 1-5 | | 合并资产负债表 | 6-7 | | 合并利润表 | 8 | | 合并现金流量表 | 9 | | 合并所有者权益变动表 | 10-11 | | 公司资产负债表 | 12 | | 公司利润表 | 13 | | 公司现金流量表 | 14 | | 公司所有者权益变动表 | 15-16 | | 财务报表附注 | 17-107 | 目 录 审 计 报 告 众会字(2025)第 03601 号 上海康鹏科技股份有限公司全体股东： (一)审计意见 我们审计了上海康鹏科技股份有限公司（以下简称"康鹏科技"）财务报表，包括 2024 年 12 月 31 日的合并及公司资产负债表，2024 年度的合并及公司利润表、合并及公司现金流量表、合并及公司所有 者权益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公允反映了康鹏科技 2024 年 12 月 31 日的合并及公司财务状况以及 2024 年度的合并及公司经营成果和现金流量。 （二） ...

中信建投证券股份有限公司 关于上海康鹏科技股份有限公司使用基本户及一般户支付 募投项目部分款项并以募集资金等额置换的核查意见 中信建投证券股份有限公司（以下简称"中信建投"或"保荐机构"）作为 上海康鹏科技股份有限公司（以下简称"康鹏科技"或"公司"）首次公开发行 股票并上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司监 管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证券交易所 科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号— —规范运作》等有关法律法规和规范性文件的规定，对康鹏科技使用基本户及一 般户支付募投项目部分款项并以募集资金等额置换事项进行了认真、审慎核查， 具体核查情况如下： 一、募集资金基本情况 2023 年 5 月 9 日经中国证券监督管理委员会《关于同意上海康鹏科技股份 有限公司首次公开发行股票注册的批复》(证监许可[2023]1007 号)同意，公司向 社会公开发行人民币普通股 10,387.5 万股股份。本次发行每股价格为人民币 8.66 元，募集资金总额人民币 899,557,500.00 元，扣除发行费用人民币 88,897, ...

上海康鹏科技股份有限公司 2024 年度 营业收入扣除情况专项审核报告 上海康鹏科技股份有限公司 2024 年度 营业收入扣除情况专项审核报告 众会字(2025)第 03606 号 上海康鹏科技股份有限公司全体股东: 我们接受委托，审计了上海康鹏科技股份有限公司（以下简称 "康鹏科技"）2024 年度的财务 报表，包括 2024 年 12 月 31 日的合并及公司资产负债表，2024 年度的合并及公司利润表、合并及公 司现金流量表、合并及公司股东权益变动表以及相关财务报表附注，并于 2025 年 4 月 16 日出具了众 会字(2025)第 03601 号审计报告。同时，我们审核了后附的康鹏科技 2024 年度营业收入扣除情况 表。 一、 管理层的责任 康鹏科技管理层的责任是提供真实、合法、完整的相关资料，按照《上海证券交易所科创板股票 上市规则》以及《科创板上市公司自律监管指南第 9 号——财务类退市指标：营业收入扣除》等要求 编制营业收入扣除情况表，并保证其内容真实、准确、完整，不存在虚假记录、误导性陈述或重大遗 漏。 二、 注册会计师的责任 我们的责任是对康鹏科技 2024 年度营业收入中是否存在与主营 ...

上海康鹏科技股份有限公司 2024 年度 内部控制审计报告 内部控制审计报告 众会字(2025)第 03604 号 上海康鹏科技股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我们审计了上海康鹏科 技股份有限公司（以下简称康鹏科技）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评价指引》的 规定，建立健全和有效实施内部控制，并评价其有效性是康鹏科技董事会的责任。 四、财务报告内部控制审计意见 我们认为，康鹏科技于 2024 年 12 月 31 日按照《企业内部控制基本规范》和相关规定在所有重 大方面保持了有效的财务报告内部控制。 1 （此页无正文） 众华会计师事务所（特殊普通合伙） 中国注册会计师 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表审计意见，并对注 意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。此外，由于情况的变化可能导 致内 ...

非经营性资金占用及其他关联资金往来情况 专项说明 上海康鹏科技股份有限公司 2024 年度 非经营性资金占用及其他关联资金往来情况 专项说明 上海康鹏科技股份有限公司 2024 年度 （此页无正文） 众会字(2025)第 03605 号 上海康鹏科技股份有限公司全体股东： 我们接受委托，依据《中国注册会计师执业准则》审计了上海康鹏科技股份有限公司(以下简称 "康鹏科技")2024 年度的财务报表，包括 2024 年 12 月 31 日的合并及公司资产负债表，2024 年度的合 并及公司利润表、合并及公司现金流量表、合并所有者权益变动表及公司所有者权益变动表以及财务 报表附注，并于 2025 年 4 月 16 日出具了众会字(2025)第 03601 号《审计报告》。 根据中国证券监督管理委员会《上市公司监管指引第 8 号——上市公司资金往来、对外担保的 监管要求》的要求以及参照上海证券交易所《上海证券交易所科创板上市公司自律监管指南第 7 号— —年度报告相关事项》规定的非经营性资金占用及其他关联资金往来情况汇总表格式，康鹏科技编制 了后附的 2024 年度非经营性资金占用及其他关联资金往来情况汇总表（以下简 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥243,177,446.14, representing a year-on-year increase of 44.27% compared to ¥168,553,569.90 in the same period last year[4] - The net profit attributable to shareholders of the listed company reached ¥30,629,054.29, a significant increase of 59.73% from ¥19,175,136.89 in the previous year[4] - Basic earnings per share increased by 50.00% to ¥0.06 from ¥0.04 in the previous year[5] - Operating profit for Q1 2025 was ¥35,530,317.84, compared to ¥21,117,251.23 in Q1 2024, reflecting a 68.3% increase[18] - Net profit for Q1 2025 was ¥30,474,142.75, up 56.7% from ¥19,441,477.03 in Q1 2024[19] Cash Flow - The net cash flow from operating activities was ¥103,812,462.17, a recovery from a negative cash flow of -¥20,741,294.03 in the same period last year[4] - Cash flow from operating activities for Q1 2025 was ¥103,812,462.17, a significant improvement from a negative cash flow of -¥20,741,294.03 in Q1 2024[21] - Cash inflow from investment activities in Q1 2025 totaled ¥472,442,856.15, compared to ¥204,112,893.57 in Q1 2024[21] - Cash outflow from investment activities in Q1 2025 was ¥718,095,973.86, down from ¥774,809,903.69 in Q1 2024[21] - The net increase in cash and cash equivalents was -166,171,630.29, compared to -563,221,202.58 in the previous period, showing an improvement of approximately 70%[22] - The ending balance of cash and cash equivalents was 555,056,796.67, up from 310,891,070.06 in the previous period, representing an increase of about 79%[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,272,666,488.63, showing a slight increase of 0.54% from ¥3,255,092,762.50 at the end of the previous year[5] - The company's current assets totaled RMB 1,859,621,394.39, compared to RMB 1,821,509,888.98 in the previous period, reflecting a growth of approximately 2.09%[14] - The company's total liabilities were RMB 454,471,698.34, down from RMB 470,718,388.95, representing a decrease of approximately 3.5%[15] - The total non-current assets were RMB 1,413,045,094.24, slightly decreasing from RMB 1,433,582,873.52[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,513[10] - The largest shareholder, Ningbo Meishan Bonded Port Area Ou Chang Investment Management Co., Ltd., held 34.66% of the shares, totaling 180,006,984 shares[10] - Total equity attributable to shareholders reached ¥2,806,084,919.62 in Q1 2025, up from ¥2,772,109,591.34 in Q1 2024[16] Research and Development - Research and development expenses totaled ¥18,511,200.74, accounting for 7.61% of operating revenue, down from 11.11% in the previous year[5] Other Financial Metrics - The weighted average return on net assets increased to 1.10%, up from 0.68% in the previous year, reflecting improved profitability[5] - Non-recurring gains and losses amounted to ¥3,360,972.39, with government subsidies contributing ¥2,968,331.33 to this total[6] - Cash flow from financing activities totaled 35,412,893.19 in the current period, compared to 52,789,606.22 in the previous period, indicating a decrease of approximately 33%[22] - The company has not adopted new accounting standards or interpretations starting from 2025[22]

Financial Performance - The company reported a profit distribution plan for 2024, stating no profit distribution, no capital reserve transfer to share capital, and no bonus shares [5]. - The company faced a decline in operating revenue due to weak overall market performance and intense domestic competition, leading to a shift from profit to loss [3]. - The company's operating revenue for 2024 was CNY 674,813,318.15, a decrease of 31.11% compared to CNY 979,591,613.03 in 2023 [23]. - The net profit attributable to shareholders for 2024 was CNY -49,531,648.34, representing a decline of 143.95% from CNY 112,699,148.17 in 2023 [23]. - The cash flow from operating activities for 2024 decreased by 71.44% to CNY 60,797,379.56 from CNY 212,849,738.16 in 2023 [23]. - The basic earnings per share for 2024 was CNY -0.10, down 140.00% from CNY 0.25 in 2023 [25]. - The net profit excluding non-recurring gains and losses for 2024 was CNY -93,595,100.90, a decline of 216.62% from CNY 80,255,581.02 in 2023 [23]. - The company reported a total revenue of 1,370.88 million RMB for the current period, a decrease from 2,269.77 million RMB in the previous period [58]. Business Strategy and Adjustments - The company is actively adjusting its business strategy to mitigate risks from external and industry factors, aiming to return to a positive operational track [3]. - The company is shifting focus from small molecules to large molecules, particularly in the peptide raw material business, to create new growth points [38]. - The company emphasizes cost control and efficiency improvements as key strategies to navigate the competitive landscape [36]. - The company plans to lower product prices in 2024 to expand market share and diversify sales, particularly in the display materials segment [40]. - The establishment of a trading company in Singapore aims to mitigate geopolitical risks and enhance market presence [37]. - The company is focusing on reducing customer concentration to mitigate risks and enhance sales diversification [46]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 12.65% in 2024 from 8.87% in 2023, an increase of 3.78 percentage points [25]. - R&D investment totaled approximately ¥85.39 million, a slight decrease of 1.69% from the previous year, with R&D expenses accounting for 12.65% of revenue, an increase of 3.78 percentage points [56]. - The company holds a total of 115 patents, including 66 invention patents and 49 utility model patents, focusing on the fluorine chemical industry [39]. - The company is increasing its R&D efforts in OLED panel technology, establishing initial contacts with overseas clients [46]. Market Conditions and Competition - The overall market environment remains challenging, with increased competition and pressure on product pricing impacting revenue and profit margins [36]. - The company experienced a significant decline in revenue due to weak market performance and intense domestic competition, leading to pressure on product prices [26]. - The CDMO segment is experiencing significant variability in customer orders due to the pharmaceutical sales plans and geopolitical risks affecting the industry [40]. - The company is a leading domestic producer of LiFSI, with plans to enhance production efficiency despite current negative gross margins due to competitive pricing pressures [47]. Corporate Governance - The company has not proposed any special arrangements for corporate governance [8]. - The company maintains a sound corporate governance structure, complying with legal and regulatory requirements [134]. - There are no significant differences between the company's governance practices and the regulations set by the China Securities Regulatory Commission [134]. - The company has not reported any issues regarding independence from its controlling shareholders [134]. - The company is committed to protecting the legal rights of all shareholders and investors [134]. Environmental and Sustainability Efforts - The company has invested 31.5781 million yuan in environmental protection during the reporting period [187]. - The company received a CCC rating from Shanghai Huazheng Index Information Service Co., Ltd. in the ESG rating system [186]. - The company has established an ESG system that includes ESG management structure, risk management, and cultural construction to promote sustainable development [185]. - The company has implemented various pollution control measures, including waste gas treatment systems such as RTO and active carbon adsorption, ensuring compliance with emission standards [189]. - The company has taken measures to reduce carbon emissions during the reporting period [200]. Shareholder and Board Activities - The company held a total of 5 shareholder meetings during the reporting period, all in compliance with relevant laws and regulations [138]. - The board of directors held a total of 8 meetings during the year, with 2 in-person and 6 via communication methods [158]. - The company plans to present its 2023 annual financial results and budget for 2024 at the annual shareholders' meeting scheduled for May 21, 2024 [136]. - The company plans to implement a restricted stock incentive plan in 2024, as discussed in the compensation committee meetings [162]. Financial Risks and Challenges - The company faces risks related to high customer concentration, which could lead to significant performance fluctuations if major clients' purchasing behavior changes [67]. - There is a risk of continuous price decline for products due to weak overall market performance and intense domestic competition [67]. - The company is exposed to foreign exchange risks due to its export business, which could affect its operating performance if the RMB experiences significant fluctuations [68]. - The company is at risk of potential penalties and operational impacts due to stricter environmental protection regulations in the fine chemical industry [66].